<![CDATA[ossur PW]]>Ossur faldr 7% pga nedjustering

]]>https://dev.proinvestor.com/forum/topic/440819/ossur-pwRSS for NodeSun, 12 Jul 2026 03:25:57 GMTTue, 14 Jan 2020 13:30:06 GMT60<![CDATA[Reply to ossur PW on Mon, 20 Jan 2020 20:36:33 GMT]]>Jeg købte i dec.-17 lige under kurs 26, så jeg klager da ikke - dobbelt op på to år. Dødvande kan jeg da ikke få øje på.

]]>https://dev.proinvestor.com/forum/post/9456913https://dev.proinvestor.com/forum/post/9456913Mon, 20 Jan 2020 20:36:33 GMT<![CDATA[Reply to ossur PW on Wed, 15 Jan 2020 10:50:16 GMT]]>Har fulgt dem i længere tid .... faktisk flere år nu, men de kommer aldrig ud af deres dødvande og derfor bliver det ALDRIG en investering i mine øjne.

]]>https://dev.proinvestor.com/forum/post/9456922https://dev.proinvestor.com/forum/post/9456922Wed, 15 Jan 2020 10:50:16 GMT<![CDATA[Reply to ossur PW on Tue, 14 Jan 2020 14:49:23 GMT]]>Jon Sigurdsson, President & CEO, comments: "The preliminary results for the
fourth quarter are disappointing while sales for the full year are strong with
growth of 16% in local currency and 5% organic growth. Despite the temporary
slowdown in prosthetics sales in the fourth quarter, we are confident that our
market position continues to be strong and we expect continued organic growth in
2020. Profitability for the full year was lower than we expected which can
largely be attributed to lower than expected sales in Q4 2019."

https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=917914&lang=en

]]>https://dev.proinvestor.com/forum/post/9456911https://dev.proinvestor.com/forum/post/9456911Tue, 14 Jan 2020 14:49:23 GMT